An exploration of the cBioPortal for cancer genomics (http://www.cbioportal.org) [54, 55] revealed that LRP5 was more frequently altered in breast cancers, mostly through amplification (TCGA [56] and METABRIC [57] cohorts), than LRP6 (Figure 1F). Here, LRP6 is linked to breast cancer.